Disseminated Intravascular Coagulation: A Practical Approach

Anesthesiology

Volumn 125, Issue 1, 2016, Pages 230-236

  Thachil, Jecko ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT PROTEIN; ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; FIBRIN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HEMOGLOBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROCOAGULANT; PROTHROMBIN COMPLEX; THROMBIN; THROMBOMODULIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; COUGHING; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DYSPNEA; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; HYPERFIBRINOLYSIS; INTERNATIONAL SOCIETY OF THROMBOSIS AND HEMOSTASIS; JAPANESE ASSOCIATION FOR ACUTE MEDICINE; JAPANESE MINISTRY OF HEALTH AND WELFARE; KIDNEY DYSFUNCTION; LABORATORY DIAGNOSIS; NOTE; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; PROCOAGULATION; PROTHROMBIN TIME; RESPIRATORY TRACT DISEASE; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA; THROMBOSIS; CASE REPORT; FEMALE; MIDDLE AGED;

ANTICOAGULANTS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; MIDDLE AGED;

EID: 84962127872     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000001123     Document Type: Note

References (27)

1. Crawley JT, Zanardelli S, Chion CK, Lane DA: The central role of thrombin in hemostasis. J Thromb Haemost 2007; 5(suppl 1):95-101
2. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M: Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH): Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86:1327-30
3. Siegal T, Seligsohn U, Aghai E, Modan M: Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): A study of 118 cases. Thromb Haemost 1978; 39:122-34
4. Yaguchi A, Lobo FL, Vincent JL, Pradier O: Platelet function in sepsis. J Thromb Haemost 2004; 2:2096-102
5. Levi M, Toh CH, Thachil J, Watson HG: Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009; 145:24-33
6. Bakhtiari K, Meijers JC, de Jonge E, Levi M: Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32:2416-21
7. Gando S, Saitoh D, Ogura H, Mayumi T, Koseki K, Ikeda T, Ishikura H, Iba T, Ueyama M, Eguchi Y, Ohtomo Y, Okamoto K, Kushimoto S, Endo S, Shimazaki S: Japanese Association for Acute Medicine Disseminated Intravascular Coagulation ( JAAM DIC) Study Group: Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey. Crit Care Med 2008; 36:145-50
8. Levi M, Meijers JC: DIC: Which laboratory tests are most useful. Blood Rev 2011; 25:33-7
9. Ono T, Mimuro J, Madoiwa S, Soejima K, Kashiwakura Y, Ishiwata A, Takano K, Ohmori T, Sakata Y: Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: Its correlation with development of renal failure. Blood 2006; 107:528-34
10. Wada H, Thachil J, Di Nisio M, Mathew P, Kurosawa S, Gando S, Kim HK, Nielsen JD, Dempfle CE, Levi M, Toh CH: The Scientific Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis: Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost 2013 [Epub ahead of print
11. Longstaff C, Adcock D, Olson JD, Jennings I, Kitchen S, Mutch N, Meijer P, Favaloro EJ, Lippi G, Thachil J: Harmonisation of D-dimer-A call for action. Thromb Res 2016; 137:219-20
12. Iba T, Ito T, Maruyama I, Jilma B, Brenner T, Müller MC, Juffermans NP, Thachil J: Potential diagnostic markers for disseminated intravascular coagulation of sepsis. Blood Rev 2015
13. Müller MC, Meijers JC, Vroom MB, Juffermans NP: Utility of thromboelastography and/or thromboelastometry in adults with sepsis: A systematic review. Crit Care 2014; 18:R30
14. Wagner DD, Frenette PS: The vessel wall and its interactions. Blood 2008; 111:5271-81
15. Sakuragawa N, Hasegawa H, Maki M, Nakagawa M, Nakashima M: Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)-A multicenter co-operative double-blind trial in comparison with heparin. Thromb Res 1993; 72:475-500
16. Frugé KS, Lee YR: Comparison of unfractionated heparin protocols using antifactor Xa monitoring or activated partial thrombin time monitoring. Am J Health Syst Pharm 2015; 72(17 suppl 2):S90-7
17. Levy JH, Sniecinski RM, Welsby IJ, Levi M: Antithrombin: Anti-inflammatory properties and clinical applications. Thromb Haemost 2015 [Epub ahead of print
18. Iba T, Saitoh D, Gando S, Thachil J: The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation. Thromb Res 2015; 135:897-901
19. Thachil J, Toh CH, Levi M, Watson HG: The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]. Br J Haematol 2012; 157:493-4
20. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD: PROWESS-SHOCK Study Group: Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012; 366:2055-64
21. U. S. Food and Drug Administration: FDA Drug Safety Communication: Voluntary market withdrawal of Xigris [drotrecogin alfa (activated)] due to failure to show a survival benefit. Available at: http://www. fda. gov/drugs/drugsafety/ ucm277114. htm. Accessed February 2, 2016
22. Iba T, Thachil J: Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: A perspective from Japan. Int J Hematol 2016; 103:253-61
23. Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, Hirayama A, Matsuda T, Asakura H, Nakashima M, Aoki N: Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: Results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 2007; 5:31-41
24. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S: CRASH-2 Trial Collaborators: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010; 376:23-32
25. Koster A, Faraoni D, Levy JH: Antifibrinolytic therapy for cardiac surgery: An update. Anesthesiology 2015; 123:214-21
26. Grottke O, Levy JH: Prothrombin complex concentrates in trauma and perioperative bleeding. Anesthesiology 2015; 122:923-31
27. Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, ten Cate H, Fitzner C, Tolba R, Rossaint R: Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 2011; 118:1943-51